About
Matt Kaeberlein is a leading aging biologist, professor at the University of Washington, and founding director of the Dog Aging Project. He is CEO of Optispan (a longevity health company), Co-Founder and Chair of Ora Biomedical (small molecule therapeutics for aging), and serves as Venture Partner at LongeVC and Advisor at Healthspan Capital. An expert on mTOR signaling and rapamycin, he is one of the most publicly visible scientists in the longevity field.
Areas of interest
longevityaging biologygerosciencemTOR / rapamycinhealthspan medicinesmall molecule therapeuticsbiomarkers of agingtranslational medicineprecision medicinecompanion animal healthclinical researchearly-stage biotech